CYTOMEGALOVIRUS REACTIVATION AND TUMOR-NECROSIS-FACTOR

被引:221
|
作者
DOCKE, WD
PROSCH, S
FIETZE, E
KIMEL, V
ZUCKERMANN, H
KLUG, C
SYRBE, U
KRUGER, DH
VONBAEHR, R
VOLK, HD
机构
[1] HUMBOLDT UNIV BERLIN,MED SCH CHARITE,INST VIROL,D-10098 BERLIN,GERMANY
[2] HUMBOLDT UNIV BERLIN,MED SCH CHARITE,DEPT SURG,D-10098 BERLIN,GERMANY
[3] HUMBOLDT UNIV BERLIN,MED SCH CHARITE,DEPT ANAESTHESIOL & INTENS CARE,D-10098 BERLIN,GERMANY
来源
LANCET | 1994年 / 343卷 / 8892期
关键词
D O I
10.1016/S0140-6736(94)91116-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tumour necrosis factor-alpha (TNF) stimulates cytomegalovirus (CMV) activity in a transfected human monocytic cell line. We assessed whether this finding is relevant in vivo by evaluating the frequency of active CMV infection in patients with diseases that enhance plasma TNF. In septic disease, peripheral blood mononuclear cells of almost all patients studied were positive for CMV. Furthermore, CMV antigenaemia and enhanced plasma TNF occurred in many patients with liver cirrhosis, common variable immunodeficiency, and B-cell chronic lymphocytic leukaemia. Thus, TNF may have a central role in CMV reactivation.
引用
收藏
页码:268 / 269
页数:2
相关论文
共 50 条
  • [31] TUMOR-NECROSIS-FACTOR (TNF) AND SEPSIS
    DUROCHER, A
    BECQ, MC
    GOSSET, P
    SAULNIER, F
    LEFEBVRE, MC
    TONNEL, AB
    CAPRON, A
    WATTEL, F
    ANNALES DE MEDECINE INTERNE, 1991, 142 (02): : 91 - 94
  • [32] REGULATION OF THE PATHOPHYSIOLOGY OF TUMOR-NECROSIS-FACTOR
    DEFORGE, LE
    NGUYEN, DT
    KUNKEL, SL
    REMICK, DG
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1990, 116 (04): : 429 - 438
  • [33] THE ROLE OF TUMOR-NECROSIS-FACTOR IN SEPSIS
    SPOONER, CE
    MARKOWITZ, NP
    SARAVOLATZ, LD
    CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 62 (01): : S11 - S17
  • [34] TUMOR-NECROSIS-FACTOR AND CEREBRAL MALARIA
    不详
    LANCET, 1987, 2 (8561): : 755 - 755
  • [35] TUMOR-NECROSIS-FACTOR - RECENT ADVANCES
    MUNKER, R
    KOEFFLER, HP
    KLINISCHE WOCHENSCHRIFT, 1987, 65 (08): : 345 - 352
  • [36] TUMOR-NECROSIS-FACTOR IN SURGICAL ILLNESS
    MCCALL, JL
    PARRY, BR
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1990, 60 (07): : 503 - 509
  • [37] IMMUNOMODULATORY EFFECT OF TUMOR-NECROSIS-FACTOR
    BONAVIDA, B
    BIOTHERAPY, 1991, 3 (02) : 127 - 133
  • [38] TUMOR-NECROSIS-FACTOR - CLINICAL IMPLICATIONS
    ROMIEU, M
    RICHE, F
    BOUSSEAU, A
    SZEKELI, B
    SCHURANDO, P
    BRIARD, C
    PAYEN, D
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 1990, 9 (06): : 525 - 535
  • [39] TUMOR-NECROSIS-FACTOR IN PARACOCCIDIOIDOMYCOSIS PATIENTS
    SILVA, CL
    FIGUEIREDO, F
    JOURNAL OF INFECTIOUS DISEASES, 1991, 164 (05): : 1033 - 1034
  • [40] THE ANTIVIRAL POTENTIAL OF TUMOR-NECROSIS-FACTOR
    KHAN, A
    PICHYANGKUL, S
    SCHICK, D
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 401 - 401